期刊文献+

YAP蛋白在老年胃癌中的表达及其对预后的影响 被引量:7

下载PDF
导出
摘要 目的探讨YAP蛋白在老年胃癌组织中的表达及其对预后的影响。方法采用免疫组化SP法检测56例老年胃癌及对应癌旁组织中YAP蛋白表达情况,分析其表达与胃癌患者预后的关系。结果 YAP蛋白在胃癌组织中的阳性率为71.4%(40/56),明显高于对应癌旁组织中的阳性率〔14.3%(8/56)〕(χ2=37.333,P=0.000);YAP蛋白在胃癌组织中的阳性表达与肿瘤大小(χ2=4.588,P=0.032)、浸润深度(χ2=5.349,P=0.021)、淋巴结转移(χ2=6.098,P=0.014)和TNM分期(χ2=5.534,P=0.019)有关;YAP蛋白阳性表达是胃癌患者预后不良的独立影响因素。结论 YAP蛋白在老年胃癌组织中的表达异常升高,且与胃癌患者预后不良相关,提示YAP蛋白在胃癌发生发展中可能发挥重要作用。
作者 罗华
机构地区 泸州医学院
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第24期6140-6141,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献12

  • 1摆斌.胃癌中MTA2、MMP-7和MMP-14的表达关系[J].中国老年学杂志,2013,33(13):3085-3087. 被引量:7
  • 2Zhou Z,Zhu JS,Xu ZP. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line[J].Mol Med Rep,2011,(06):1075-1082.
  • 3Steinhardt AA,Gayyed MF,Klein AP. Expression of Yes-associated protein in common solid tumors[J].{H}Human Pathology,2008,(11):1582-1589.
  • 4Lam-Himlin DM,Daniels JA,Gayyed MF. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma:a novel oncogenic pathway[J].{H}INTERNATIONAL JOURNAL OF GASTROINTESTINAL CANCER,2006,(04):103-109.
  • 5周振宇,涂康生,张竞,郑鑫,高洁,姚英民,刘青光.Fbxw7在肝癌中的表达及与肝癌细胞增殖相关性研究[J].细胞与分子免疫学杂志,2012,28(12):1303-1306. 被引量:26
  • 6Pan D. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy(CLASSIC):a phase 3 open-label,randomised controlled trial[J].{H}LANCET,2012,(9813):315-321.
  • 7Wang L,Shi S,Guo Z. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J].PLoS One,2013,(06):e65539.
  • 8Yu FX,Zhao B,Panupinthu N. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling[J].{H}CELL,2012,(04):780-791.
  • 9Barry ER,Camargo FD. The Hippo superhighway:signaling crossroads converging on the Hippo/Yap pathway in stem cells and development[J].{H}Current Opinion in Cell Biology,2013,(02):247-253.
  • 10Overholtzer M,Zhang J,Smolen GA. Transforming properties of YAP,a candidate oncogene on the chromosome 11 q22 amplicon[J].{H}Proceedings of the National Academy of Sciences(USA),2006,(33):12405-12410.

二级参考文献25

  • 1Frau M, Biasi F, Feo F, et al. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma [ J]. Mol Aspects Med, 2010, 31(2) : 179 -193.
  • 2Akhoondi S, Sun D, van der Lehr N, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer[ J]. Cancer Res, 2007, 67 (19) : 9006-9012.
  • 3Mao JH, Perez-Losada J, Wu D, et al. Fbxw7/Cde4 is a p53-dependent, haploinsufficient tumour suppressor gene[ J]. Nature, 2004, 432 (9) : 775 - 779.
  • 4Liu YH, Tong ZW, Li T, et al. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness [ J ]. Hepatology, 2012, 56(3) : 1015 -1024.
  • 5Chen MC, Chen CH, Chuang HC, et al. A novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase Ⅱα degradation in hepatocellular carcinoma cells[ J]. Hepatology, 2011,53 ( 1 ) : 148 -159.
  • 6Tu KS, Zheng X, Liu QG, et al. Evaluation of Fbxw7 expression and its correlation with the expression of e-Mye, eyelin E and p53 in human hepatocellular carcinoma [ J ]. Hepatol Res, 2012, 42 (9) : 904 -910.
  • 7Bashir T, Pagano M. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis [ J/OA ]. Adv Cancer Res, 2003, 88 : 101 - 144.
  • 8Livnat-Levanon N, Glickman MH. Ubiquitin-proteasome system and mitochondria-reciprocity [ J]. Biochim Biophys Acta, 2011, 1809 (2) : 80 -87.
  • 9Kimura T, Gotoh M, Nakamura Y, et al. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53 [ J ]. Cancer Sci, 2003, 94(5): 431 -436.
  • 10Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation[ J]. Nat Rev Cancer, 2008, 8(2) : 83 -93.

共引文献31

同被引文献40

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部